Preferred Label : 4-phenylbutyric acid;
MeSH note : RN refers to the parent cpd;
CISMeF synonym : 4-phenylbutyrate; ammonaps; buphenyl; orphan brand of 4-phenylbutyric acid, sodium salt; ucyclyd brand of 4-phenylbutyric acid, sodium salt;
MeSH hyponym : sodium 4-phenylbutanoate; sodium phenylbutyrate; sodium 4-phenylbutyrate;
CISMeF CAS label : acide 4-phénylbutyrique;
MeSH Related Number : 4-phenylbutyric acid, calcium salt; 4-phenylbutyric acid, sodium salt; 1716-12-7 (Na); 1821-12-1 (4-phenylbutyric acid); 92410-95-2 (Ca); 1716-12-7 (4-phenylbutyric acid, sodium salt); NT6K61736T;
Registry Number MeSH : 1821-12-1;
Related CAS MeSH : 92410-95-2 (4-phenylbutyric acid, calcium salt); 1716-12-7 (4-phenylbutyric acid, sodium salt);
related registry number list (CISMeF) : 1716-12-7 (Na); 92410-95-2 (Ca);
CISMeF hyponym : phénylbutyrate de sodium; sodium phénylbutyrate;
Codes EINECS : 217-341-8;
Is substance : O;
UNII : 7WY7YBI87E;
InChIKey : OBKXEAXTFZPCHS-UHFFFAOYSA-N;
Origin ID : C075773;
UMLS CUI : C0170531;
ATC code(s)
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
Validated automatic mappings to NTBT
https://www.has-sante.fr/jcms/p_3576423/fr/pheburane-phenylbutyrate-de-sodium-desordres-du-cycle-de-l-uree
2025
false
false
false
France
pharmaceutical solutions
administration, oral
treatment outcome
insurance, health, reimbursement
sodium phenylbutyrate
4-phenylbutyric acid
carbamoyl-phosphate synthase i deficiency disease
citrullinemia
ornithine carbamoyltransferase deficiency disease
evaluation of the transparency committee
phenylbutyrates
4-phenylbutyric acid, sodium salt
---
http://www.has-sante.fr/portail/jcms/c_1720968/fr/pheburane-phenylbutyrate-de-sodium
2014
false
France
French
orphan drug production
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid
4-phenylbutyric acid
sodium phenylbutyrate
administration, oral
citrullinemia
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
treatment outcome
evaluation of the transparency committee
guidelines for drug use
continuity of patient care
therapeutic equivalency
randomized controlled trials as topic
phenylbutyrates
phenylbutyrates
---
http://www.has-sante.fr/portail/jcms/c_1720968/fr/pheburane
http://www.has-sante.fr/portail/jcms/c_1720967/fr/pheburane22012014avisct13341
2014
false
France
French
evaluation of the transparency committee
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid, sodium salt
administration, oral
sodium phenylbutyrate
urea cycle disorders, inborn
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
4-phenylbutyric acid
4-phenylbutyric acid
continuity of patient care
infant, newborn
infant
child
adolescent
adult
treatment outcome
citrullinemia
phenylbutyrates
phenylbutyrates
guidelines for drug use
---
https://www.ema.europa.eu/medicines/human/EPAR/Pheburane
2013
false
United Kingdom
French
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid, sodium salt
drug approval
europe
treatment outcome
sodium phenylbutyrate
urea cycle disorders, inborn
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
citrullinemia
administration, oral
hyperammonemia
4-phenylbutyric acid
4-phenylbutyric acid
summary of product characteristics
package leaflet
drug evaluation
syndication feed
drug interactions
pregnancy
breast feeding
prodrugs
phenylacetate
phenylacetic acid
drug evaluation, preclinical
phenylacetates
phenylbutyrates
phenylbutyrates
---
https://www.ema.europa.eu/medicines/human/EPAR/Ammonaps
2011
United Kingdom
English
French
syndication feed
4-phenylbutyric acid
sodium phenylbutyrate
infant
child
adult
treatment outcome
pregnancy
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid, sodium salt
drug evaluation
summary of product characteristics
package leaflet
4-phenylbutyric acid
administration, oral
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
citrullinemia
urea cycle disorders, inborn
phenylacetic acid
breast feeding
drug interactions
drug approval
europe
phenylacetate
hyperammonemia
phenylacetates
phenylbutyrates
phenylbutyrates
---
http://www.has-sante.fr/portail/display.jsp?id=c_241518
2001
France
French
antineoplastic agents
phenylbutyrates
ornithine carbamoyltransferase deficiency disease
child
carbamoyl-phosphate synthase (ammonia)
argininosuccinate synthase
citrullinemia
infant, newborn
ornithine carbamoyltransferase
infant
sodium phenylbutyrate
4-phenylbutyric acid, sodium salt
4-phenylbutyric acid
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_241518
2001
France
French
phenylbutyrates
antineoplastic agents
4-phenylbutyric acid
sodium phenylbutyrate
4-phenylbutyric acid, sodium salt
guidelines for drug use
---